The company has received abbreviated new drug application (ANDA) approval for its Amiodarone tablets, USP, 200 mg from the United States Food and Drug Administration (USFDA), Unichem Labs said in a filing to the BSE.

Unichem Laboratories Ltd. has lost -25.17% in the last 6 Months

Unichem Laboratories Ltd.

22 Jul 2020, 12:48PM

642.00

2.65%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Announcement Under Reuglation 30 (LODR) - ANDA Approval From USFDA …

BSE India

Announcement under Reuglation 30 (LODR) - ANDA Approval from USFDA for Unichem's Amiodarone Tablets

pdf

Unichem Laboratories Ltd.

14 Jul 2020

642.00

2.65%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Shareholding for the Period Ended June 30, 2020

BSE India

Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here

Unichem Laboratories Ltd.

11 Jul 2020

642.00

2.65%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020.

pdf

Unichem Laboratories Ltd.

11 Jul 2020

642.00

2.65%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Statement Of Investor Complaints For The Quarter Ended June 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- PRADEEP BHANDARIDesignation :- Company Secretary and Compliance Officer